Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion.
Li P, Faraone JN, Hsu CC, Chamblee M, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Xu K, Liu SL. Li P, et al. Among authors: bednash js. bioRxiv [Preprint]. 2024 May 21:2024.05.20.595020. doi: 10.1101/2024.05.20.595020. bioRxiv. 2024. PMID: 38826376 Free PMC article. Preprint.
SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.
Pannu S, Exline MC, Bednash JS, Englert JA, Diaz P, Bartlett A, Brock G, Wu Q, Davis IC, Crouser ED. Pannu S, et al. Among authors: bednash js. Trials. 2024 May 18;25(1):328. doi: 10.1186/s13063-024-08155-0. Trials. 2024. PMID: 38760804 Free PMC article. Clinical Trial.
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion.
Li P, Liu Y, Faraone J, Hsu CC, Chamblee M, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Liu SL. Li P, et al. Among authors: bednash js. bioRxiv [Preprint]. 2024 Mar 11:2024.03.11.583978. doi: 10.1101/2024.03.11.583978. bioRxiv. 2024. PMID: 38559216 Free PMC article. Updated. Preprint.
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
Qu P, Xu K, Faraone JN, Goodarzi N, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Gumina RJ, Liu SL. Qu P, et al. Among authors: bednash js. Cell. 2024 Feb 1;187(3):585-595.e6. doi: 10.1016/j.cell.2023.12.026. Epub 2024 Jan 8. Cell. 2024. PMID: 38194968 Free PMC article.
Synergistic Role of NK Cells and Monocytes in Promoting Atherogenesis in Severe COVID-19 Patients.
Gunasena M, Alles M, Wijewantha Y, Mulhern W, Bowman E, Gabriel J, Kettelhut A, Kumar A, Weragalaarachchi K, Kasturiratna D, Horowitz JC, Scrape S, Pannu SR, Liu SL, Vilgelm A, Wijeratne S, Bednash JS, Demberg T, Funderburg NT, Liyanage NPM. Gunasena M, et al. Among authors: bednash js. medRxiv [Preprint]. 2023 Nov 12:2023.11.10.23298322. doi: 10.1101/2023.11.10.23298322. medRxiv. 2023. PMID: 37986806 Free PMC article. Preprint.
A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection.
Farkas D, Bogamuwa S, Piper B, Newcomb G, Gunturu P, Bednash JS, Londino JD, Elhance A, Nho R, Mejia OR, Yount JS, Horowitz JC, Goncharova EA, Mallampalli RK, Robinson RT, Farkas L. Farkas D, et al. Among authors: bednash js. bioRxiv [Preprint]. 2023 Jan 25:2023.01.25.524586. doi: 10.1101/2023.01.25.524586. bioRxiv. 2023. PMID: 36747676 Free PMC article. Preprint.
30 results